Showing results (401-410 of 785) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|October 2, 2019
Mosaic effectiveness: measuring the impact of novel PrEP methodsDavid V Glidden, Megha L Mehrotra, David T Dunn, et al.
The Lancet. HIV|March 19, 2019
Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trialEvgeny Krupitsky, Elena Blokhina, Edwin Zvartau, et al.
The Lancet. HIV|September 10, 2019
Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic studyKimberly K Scarsi, Yoninah S Cramer, Susan L Rosenkranz, et al.
The Lancet. HIV|March 1, 2019
Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trialStéphane Blanche, Thorkild Tylleskär, Marianne Peries, et al.
The Lancet. HIV|February 14, 2021
Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort studyGoodluck W Lyatuu, Shally Z Mwashemele, Roseline Urrio, et al.
The Lancet. HIV|February 22, 2017
Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trialPaul E Sax, Edwin DeJesus, Gordon Crofoot, et al.
The Lancet. HIV|March 6, 2017
Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority studyEdwin DeJesus, Moti Ramgopal, Gordon Crofoot, et al.
The Lancet. HIV|October 4, 2019
Conditional economic incentives to improve HIV prevention and treatment in low-income and middle-income countriesOmar Galárraga, Sandra G Sosa-Rubí
The Lancet. HIV|April 12, 2025
Impact of quasi-elimination of Wuchereria bancrofti on HIV incidence in southwest Tanzania: a 12-year prospective cohort studyInge Kroidl, Thomas F Marandu, Lucas Maganga, et al.
The Lancet. HIV|April 28, 2025
The impact of homelessness and housing insecurity on HIVJulia C Dombrowski, Maria A Corcorran, Tara Carney, et al.
Pageof 79